DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Patrick Vallance
Patrick Vallance
Second Quarter 2017
The Academy of Medical Sciences Review 2006 Fmedsci Contents
Third Annual World Congress on the Insulin Resistance Syndrome Atherothrombotic Disease
Connecting Immunology
Newsletter Spring 2018 This Is Engineering Campaign Goes Live
E2017137 (PDF)
Imperialmatters
The Ship 2013/2014
Glaxosmithkline, Parent Company of Stiefel, a GSK Company
100 Days Mission to Respond to Future Pandemic Threats
A Blueprint for Dynamic Oversight How the UK Can Take a Global Lead in Emerging Science and Technologies
A Map of the Alternative Biomedical R&D Landscape
Annual Report 2015
Future Skills for the Life Sciences: Conference Report March 2019
Science Advisory Group for the Review of Potential Environmental Contamination in Grenfell and North Kensington
Annual Report 2017
Part 3 Immuno-Inflammation, Oncology & Rare Diseases
Policy Implications of Models of the Spread of Coronavirus: Perspectives and Opportunities for Economists1
Top View
Glaxosmithkline Plc (GSK) J.P
Annual Report 2020 We Are a Science-Led Global Healthcare Company
Covid-19, Trust, and Wellcome
Part 1 HIV, Infectious Diseases, Respiratory & PHI Patrick Vallance
R&D Seminar: Late-Stage Pipeline Review
The UK's Contribution to Health Globally – 2020 Update
Glaxosmithkline Appoints Zhi Hong to Head Infectious-Diseases Rese
PPCO Twist System
Remuneration
Emqs in CLINICAL MEDICINE This Page Intentionally Left Blank Emqs in CLINICAL MEDICINE
GSK Annual Report & Accounts 2011
The Influence of the Pharmaceutical Industry
A Mixed Methods Study of Antidepressant Use and Withdrawal
Covid-19 Vaccine
Health Data Science in the COVID-19 Era
Springer Book Archives Seite 1 Title 1980
SAGE COVID-19 Register of Participants' Interests Sir Patrick Vallance FRS Fmedsci FRCP Professor Chris Whitty CB Fmedsci Prof
In This Issue